✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Humanwell Healthcare (Group) Co Ltd

Common Name
Humanwell Healthcare (Group)
Country
China (Mainland)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
17,153
Ticker
600079
Exchange
SHANGHAI STOCK EXCHANGE
Description
Humanwell Healthcare Group Co., Ltd. is a prominent player in the healthcare sector, known for its comprehensive approach to delivering high-quality pharmaceutical products and services. The company i...

Humanwell Healthcare (Group)'s GHG Emissions Data Preview

In 2024, Humanwell Healthcare (Group) completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Humanwell Healthcare (Group) has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024202320222021-2019
Total Scope 1
19,500a
23,403.28b
14,164.74b
Total Scope 2
Unspecified Calculation Method
106,000a
132,218.74b
166,996.83b
Total Scope 3
N/AN/AN/A
Total Scope 1 Revenue Intensity (tCO2e/$M)
5.5951a
6.782b
4.4154b
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=600079&reporting_period=2024"

Verified Sources Behind Humanwell Healthcare (Group)’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Humanwell Healthcare (Group)'s ESG Report 2024
b. Humanwell Healthcare (Group)'s CSR Report 2023

Insights into Humanwell Healthcare (Group)'s Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Humanwell Healthcare (Group) amounted to 125,500 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Humanwell Healthcare (Group) decreased by 19.36%, showing that the company has made progress in taking action to reduce the climate impact of its operations.ab

Humanwell Healthcare (Group)'s Scope 1 Emissions Over Time

202120222023202406 k12 k18 k24 ktCO2e-12%+65%-17%
  • Total Scope 1
  • Year-over-Year Change

What are Humanwell Healthcare (Group)'s Scope 1 emissions?

In 2024, the total Scope 1 emissions of Humanwell Healthcare (Group) were 19,500 metric tons of CO₂ equivalent (tCO₂e).a

Has Humanwell Healthcare (Group) reduced its Scope 1 emissions over time?

Since 2021, Humanwell Healthcare (Group)'s Scope 1 emissions have increased by 21.44%, reflecting a rising long-term trend in Scope 1 emissions over time.ab

Compared to the previous year (2023), Humanwell Healthcare (Group)'s Scope 1 emissions decreased by 16.68%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.ab

What are Humanwell Healthcare (Group)'s Scope 2 emissions?

In 2024, Humanwell Healthcare (Group) reported Scope 2 greenhouse gas (GHG) emissions of 106,000 tCO₂e without specifying the calculation method.a

Has Humanwell Healthcare (Group) reduced its Scope 2 emissions over time?

Since 2021, Humanwell Healthcare (Group)'s Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have decreased by 42.77%, reflecting a declining long-term trend in Scope 2 emissions over time.ab

Compared to the previous year (2023), Humanwell Healthcare (Group)'s Scope 2 emissions (Unspecified Calculation Method) fell by 19.83% in 2024, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption.ab

What methodology does Humanwell Healthcare (Group) use for Scope 2 reporting?

In 2024, Humanwell Healthcare (Group) reported its Scope 2 emissions using an unspecified methodology.a

Humanwell Healthcare (Group)'s Scope 2 Emissions Over Time

2021202220232024050 k100 k150 k200 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Humanwell Healthcare (Group)’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Humanwell Healthcare (Group) reported Scope 1 greenhouse gas (GHG) emissions of 19,500 tCO₂e and total revenues of USD 3,485 millions. This translates into an emissions intensity of 5.6 tCO₂e per millions USD.a

Humanwell Healthcare (Group)'s Scope 1 Emissions Intensity Compared to Peers

5005,00050,000500,0002,000,000Scope 1 Emissions (tCO2e)201005002,00010,000Revenues (Millions of USD)Luye Pharma GroupYear: 2023Scope 1: 10,755 tCO2eRevenue: $M 864Scope 1 Intensity: 12.44 tCO2e/$MSihuan PharmaceuticalYear: 2023Scope 1: 45,602 tCO2eRevenue: $M 262Scope 1 Intensity: 174.19 tCO2e/$MConsun Pharmaceutical GroupYear: 2023Scope 1: 54,210 tCO2eRevenue: $M 364Scope 1 Intensity: 148.75 tCO2e/$MZhejiang Jiuzhou PharmaceuticalYear: 2023Scope 1: 48,815 tCO2eRevenue: $M 777Scope 1 Intensity: 62.81 tCO2e/$MCanSino BiologicsYear: 2023Scope 1: 3,541 tCO2eRevenue: $M 49Scope 1 Intensity: 72.91 tCO2e/$MHepalinkYear: 2024Scope 1: 18,284 tCO2eRevenue: $M 721Scope 1 Intensity: 25.37 tCO2e/$MHuadong MedicineYear: 2024Scope 1: 15,595 tCO2eRevenue: $M 5,742Scope 1 Intensity: 2.72 tCO2e/$MFosun PharmaYear: 2024Scope 1: 184,016 tCO2eRevenue: $M 5,627Scope 1 Intensity: 32.70 tCO2e/$MYunnan Baiyao GroupYear: 2024Scope 1: 15,079 tCO2eRevenue: $M 5,485Scope 1 Intensity: 2.75 tCO2e/$MBioKangtaiYear: 2023Scope 1: 15,952 tCO2eRevenue: $M 489Scope 1 Intensity: 32.60 tCO2e/$MCR Double-CraneYear: 2024Scope 1: 58,155 tCO2eRevenue: $M 1,536Scope 1 Intensity: 37.86 tCO2e/$MWalvax BiotechnologyYear: 2024Scope 1: 7,643 tCO2eRevenue: $M 387Scope 1 Intensity: 19.77 tCO2e/$MTasly Pharmaceutical GroupYear: 2024Scope 1: 37,370 tCO2eRevenue: $M 1,164Scope 1 Intensity: 32.09 tCO2e/$MApeloa PharmaceuticalYear: 2024Scope 1: 10,400 tCO2eRevenue: $M 1,647Scope 1 Intensity: 6.31 tCO2e/$MLivzon Pharmaceutical GroupYear: 2024Scope 1: 194,441 tCO2eRevenue: $M 1,619Scope 1 Intensity: 120.13 tCO2e/$MChangchun High-TechYear: 2023Scope 1: 61,590 tCO2eRevenue: $M 2,050Scope 1 Intensity: 30.05 tCO2e/$MSimcere Pharmaceutical GroupYear: 2023Scope 1: 4,997 tCO2eRevenue: $M 930Scope 1 Intensity: 5.37 tCO2e/$MDa Ren TangYear: 2023Scope 1: 5,902 tCO2eRevenue: $M 1,157Scope 1 Intensity: 5.10 tCO2e/$MDong-E-E-JiaoYear: 2023Scope 1: 15,659 tCO2eRevenue: $M 663Scope 1 Intensity: 23.60 tCO2e/$MZhejiang NhuYear: 2024Scope 1: 765,023 tCO2eRevenue: $M 2,961Scope 1 Intensity: 258.37 tCO2e/$MHansoh Pharmaceutical GroupYear: 2024Scope 1: 13,163 tCO2eRevenue: $M 1,680Scope 1 Intensity: 7.84 tCO2e/$MJiangsu Hengrui PharmaceuticalsYear: 2024Scope 1: 8,517 tCO2eRevenue: $M 3,835Scope 1 Intensity: 2.22 tCO2e/$MJoincareYear: 2024Scope 1: 197,854 tCO2eRevenue: $M 2,140Scope 1 Intensity: 92.45 tCO2e/$MBeijing Tong Ren TangYear: 2024Scope 1: 34,974 tCO2eRevenue: $M 2,548Scope 1 Intensity: 13.72 tCO2e/$MChina Resources SanjiuYear: 2024Scope 1: 55,312 tCO2eRevenue: $M 3,784Scope 1 Intensity: 14.62 tCO2e/$MHumanwell Healthcare (Group)Year: 2024Scope 1: 19,500 tCO2eRevenue: $M 3,485Scope 1 Intensity: 5.60 tCO2e/$M

How does Humanwell Healthcare (Group)'s GHG emissions intensity compare to its peers?

In 2024, Humanwell Healthcare (Group) reported a Scope 1 emissions intensity of 5.6 tCO₂e per millions USD. Compared to the peer group median of 25.37, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a

Where does Humanwell Healthcare (Group) rank on GHG emissions intensity within its industry?

In 2024, Humanwell Healthcare (Group) ranked 6 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a

Humanwell Healthcare (Group) is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a

Want Full Access to Humanwell Healthcare (Group)'s GHG Emissions Dataset?
Start 30-Day Free Trial